HTF9 Inhibitors
HTF9 Inhibitors encompass a range of chemical compounds that interact with specific signaling pathways or cellular processes, which can result in the decreased activity of the protein HTF9. These inhibitors can function through direct interaction with the protein or indirectly by affecting pathways that modulate the protein's activity. Staurosporine, for example, is a broad-spectrum kinase inhibitor that can diminish the activity of HTF9 by preventing necessary phosphorylation events. On the other hand, LY294002 and Wortmannin both act as inhibitors of PI3K, leading to the suppression of the PI3K/AKT signaling pathway; if HTF9 relies on this pathway for its function, these inhibitors can lead to a decrease in its activity.
Continuing with the diverse mechanisms of HTF9 inhibitors, rapamycin's inhibition of mTOR can affect HTF9 if it is influenced by mTOR signaling. SB203580 and PD98059 target the p38 MAPK and MEK enzymes respectively, which are part of the MAPK/ERK pathway. If HTF9 is a downstream effector in this pathway, these inhibitors can decrease its activity.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can inhibit a wide range of protein kinases. It affects the phosphorylation state of various proteins, leading to altered signaling pathways. In the context of HTF9, if it is a protein that relies on phosphorylation for activity, staurosporine can directly inhibit its function by preventing this post-translational modification. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, leading to the blockade of the PI3K/AKT signaling pathway. If HTF9's activity is downstream of or regulated by PI3K/AKT signaling, LY294002 can lead to decreased functional activity of HTF9 by inhibiting this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor which can suppress the mTOR pathway, a key regulator of cell growth and metabolism. If HTF9 is a protein whose stability or activity is modulated by mTOR signaling, rapamycin can indirectly decrease its functional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 MAPK, impacting stress response and inflammatory signaling. If HTF9 operationally interacts with the p38 MAPK pathway, SB203580 can reduce HTF9's activity by inhibiting this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor which disrupts the MAPK/ERK pathway. If HTF9 is activated by or associated with the MAPK/ERK signaling, PD98059 can indirectly lead to its functional inactivation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Another MEK inhibitor similar to PD98059. It specifically inhibits MEK1/2, leading to ERK pathway inhibition. If HTF9 is implicated in this pathway, U0126 can lead to a reduction in HTF9's activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can prevent the degradation of ubiquitinated proteins. If HTF9 is part of a feedback loop regulated by proteasomal degradation, bortezomib can alter its functional activity indirectly. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
An inhibitor of the Hedgehog (Hh) signaling pathway by binding to Smoothened. If HTF9 is regulated through Hh signaling, cyclopamine can decrease its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, affecting the JNK signaling pathway involved in stress response. If HTF9's activity is modulated by JNK signaling, SP600125 can lead to decreased activity of HTF9. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent inhibitor of PI3K like LY294002. If HTF9's activity is PI3K-dependent, wortmannin can cause a reduction in HTF9's functional activity. | ||||||